Allspring Global Investments Holdings LLC lessened its stake in shares of TriMas Co. (NASDAQ:TRS – Free Report) by 0.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,126,743 shares of the industrial products company’s stock after selling 18,493 shares during the period. Allspring Global Investments Holdings LLC owned 7.71% of TriMas worth $74,542,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Inspire Investing LLC raised its holdings in shares of TriMas by 17.4% during the third quarter. Inspire Investing LLC now owns 16,155 shares of the industrial products company’s stock valued at $412,000 after acquiring an additional 2,389 shares during the last quarter. Impax Asset Management Group plc increased its position in shares of TriMas by 216.4% during the third quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company’s stock worth $10,467,000 after purchasing an additional 280,431 shares in the last quarter. State of New Jersey Common Pension Fund D raised its stake in TriMas by 8.6% in the 3rd quarter. State of New Jersey Common Pension Fund D now owns 79,822 shares of the industrial products company’s stock valued at $2,038,000 after purchasing an additional 6,344 shares during the last quarter. Sasco Capital Inc. CT lifted its holdings in TriMas by 26.6% in the 3rd quarter. Sasco Capital Inc. CT now owns 44,980 shares of the industrial products company’s stock valued at $1,148,000 after purchasing an additional 9,460 shares in the last quarter. Finally, Intech Investment Management LLC acquired a new stake in TriMas during the 3rd quarter worth $269,000. 99.42% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
TRS has been the subject of a number of recent research reports. StockNews.com raised shares of TriMas from a “sell” rating to a “hold” rating in a research note on Wednesday, November 13th. BWS Financial reissued a “buy” rating and issued a $40.00 target price on shares of TriMas in a research note on Thursday, January 23rd.
TriMas Stock Performance
NASDAQ TRS opened at $23.76 on Thursday. TriMas Co. has a fifty-two week low of $22.24 and a fifty-two week high of $28.51. The firm has a market capitalization of $963.94 million, a P/E ratio of 37.13 and a beta of 0.66. The stock’s fifty day moving average is $24.55 and its two-hundred day moving average is $25.24. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83.
TriMas Company Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories
- Five stocks we like better than TriMas
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- What Are the FAANG Stocks and Are They Good Investments?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.